Jakafi 10 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCRT8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,327
Award facts
- Contract value 100% obligated
- $25,326.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,326.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of January 9, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors supplying pharmaceutical products to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has held its PPV-G GEN V contract since November 13, 2025, with a ceiling value of $499,999,999 and completion through December 31, 2036, comprising a 30-month base period and three 30-month option periods. The contractor's extensive product portfolio includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, positioning the company as a critical supplier within the federal military medical supply chain. This delivery order represents one of numerous awards issued to the contractor by the Defense Logistics Agency's Medical Supply Chain division, reflecting consistent performance across multiple therapeutic categories and product lines.
Quick answers
Who was awarded contract SPE2DR26FCRT8?
SPE2DR26FCRT8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FCRT8 worth?
The government has obligated $25,327 on SPE2DR26FCRT8.
Is contract SPE2DR26FCRT8 an order under another contract?
Yes. SPE2DR26FCRT8 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRT8 competed?
The extent of competition for SPE2DR26FCRT8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award